144 related articles for article (PubMed ID: 11979557)
1. Suppression of the tumorigenic phenotype by chromosome 18 transfer into pancreatic cancer cell lines.
Lefter LP; Furukawa T; Sunamura M; Duda DG; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A
Genes Chromosomes Cancer; 2002 Jun; 34(2):234-42. PubMed ID: 11979557
[TBL] [Abstract][Full Text] [Related]
2. Transfer of chromosome 18 into human head and neck squamous carcinoma cells: evidence for tumor suppression by Smad4/DPC4.
Reiss M; Santoro V; de Jonge RR; Vellucci VF
Cell Growth Differ; 1997 Apr; 8(4):407-15. PubMed ID: 9101086
[TBL] [Abstract][Full Text] [Related]
3. Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis.
Inoue H; Furukawa T; Sunamura M; Takeda K; Matsuno S; Horii A
Genes Chromosomes Cancer; 2001 Jul; 31(3):295-9. PubMed ID: 11391801
[TBL] [Abstract][Full Text] [Related]
4. Screening for functional tumor suppressor activity in pancreatic cancer.
Lefter L; Scripcaru V; Sunamura M; Furukawa T; Matsuno S; Oshimura M; Drug V; Dragomir C; Horii A
Rom J Gastroenterol; 2004 Sep; 13(3):195-201. PubMed ID: 15470531
[TBL] [Abstract][Full Text] [Related]
5. Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype.
Lefter LP; Sunamura M; Furukawa T; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A
Clin Cancer Res; 2003 Oct; 9(13):5044-52. PubMed ID: 14581380
[TBL] [Abstract][Full Text] [Related]
6. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
7. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
[TBL] [Abstract][Full Text] [Related]
8. Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells.
Duda DG; Sunamura M; Lefter LP; Furukawa T; Yokoyama T; Yatsuoka T; Abe T; Inoue H; Motoi F; Egawa S; Matsuno S; Horii A
Oncogene; 2003 Oct; 22(44):6857-64. PubMed ID: 14534532
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
[TBL] [Abstract][Full Text] [Related]
10. Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells.
Müller N; Reinacher-Schick A; Baldus S; van Hengel J; Berx G; Baar A; van Roy F; Schmiegel W; Schwarte-Waldhoff I
Oncogene; 2002 Sep; 21(39):6049-58. PubMed ID: 12203117
[TBL] [Abstract][Full Text] [Related]
11. [The effects of transferring DPC4-adenovirus on pancreatic adenocarcinoma cells].
Feng XL; Zhang ZD; Tian L; Wei YQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):607-11. PubMed ID: 15460398
[TBL] [Abstract][Full Text] [Related]
12. The role of chromosome 18 abnormalities in the progression of pancreatic adenocarcinoma.
Sunamura M; Lefter LP; Duda DG; Morita R; Inoue H; Yokoyama T; Yatsuoka T; Abe T; Egawa S; Furukawa T; Fukushige S; Oshimura M; Horii A; Matsuno S
Pancreas; 2004 Apr; 28(3):311-6. PubMed ID: 15084978
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of Smad4 in gastric carcinomas.
Powell SM; Harper JC; Hamilton SR; Robinson CR; Cummings OW
Cancer Res; 1997 Oct; 57(19):4221-4. PubMed ID: 9331080
[TBL] [Abstract][Full Text] [Related]
14. SMAD4/DPC4 and pancreatic cancer survival. Commentary re: M. Tascilar et al., The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin. Cancer Res., 7: 4115-4121, 2001.
Liu F
Clin Cancer Res; 2001 Dec; 7(12):3853-6. PubMed ID: 11751474
[No Abstract] [Full Text] [Related]
15. No SMAD4 hypermethylation in colorectal cancer.
Roth S; Laiho P; Salovaara R; Launonen V; Aaltonen LA
Br J Cancer; 2000 Oct; 83(8):1015-9. PubMed ID: 10993648
[TBL] [Abstract][Full Text] [Related]
16. Smad4 deficiency in cervical carcinoma cells.
Baldus SE; Schwarz E; Lohrey C; Zapatka M; Landsberg S; Hahn SA; Schmidt D; Dienes HP; Schmiegel WH; Schwarte-Waldhoff I
Oncogene; 2005 Jan; 24(5):810-9. PubMed ID: 15531914
[TBL] [Abstract][Full Text] [Related]
17. Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer.
Kruzelock RP; Cuevas BD; Wiener JR; Xu FJ; Yu Y; Cabeza-Arvelaiz Y; Pershouse M; Lovell MM; Killary AM; Mills GB; Bast RC
Oncogene; 2000 Dec; 19(54):6277-85. PubMed ID: 11175342
[TBL] [Abstract][Full Text] [Related]
18. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.
Wada M; Yazumi S; Takaishi S; Hasegawa K; Sawada M; Tanaka H; Ida H; Sakakura C; Ito K; Ito Y; Chiba T
Oncogene; 2004 Mar; 23(13):2401-7. PubMed ID: 14743205
[TBL] [Abstract][Full Text] [Related]
19. [SMAD4/DPC4 (small mothers against decapentaplegic deleted in pancreatic carcinoma, locus 4). Tumor suppressor gene].
Bull Cancer; 1998 Oct; 85(10):832. PubMed ID: 9867367
[No Abstract] [Full Text] [Related]
20. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
Jazag A; Ijichi H; Kanai F; Imamura T; Guleng B; Ohta M; Imamura J; Tanaka Y; Tateishi K; Ikenoue T; Kawakami T; Arakawa Y; Miyagishi M; Taira K; Kawabe T; Omata M
Oncogene; 2005 Jan; 24(4):662-71. PubMed ID: 15592526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]